Article Text

Download PDFPDF
CASE REPORT
Successful treatment of Sydenham's chorea with intravenous immunoglobulin
  1. Nienke Anne Boersma1,
  2. Herman Schippers2,
  3. Taco Kuijpers3,
  4. Jojanneke Heidema4
  1. 1Department of Pediatrics, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands
  2. 2Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands
  3. 3Department of Pediatric Hematology, Immunology & Infectious Disease, Academic Medical Centre, Amsterdam, The Netherlands
  4. 4Department of Paediatrics, St. Antonius Hospital, Nieuwegein, The Netherlands
  1. Correspondence to Dr Jojanneke Heidema, j.heidema{at}antoniusziekenhuis.nl

Summary

We present a case of a 10-year-old girl diagnosed with Sydenham's chorea. Despite treatment with haloperidol and valproic acid for 2 weeks and antibiotics for 5 days, her symptoms continued to worsen. She became severely impaired in daily functioning, as she could barely speak or walk, experienced major feeding difficulties and required help with all daily activities. She was treated with intravenous immunoglobulin (IVIG). Within 4 days, her symptoms started to improve and after 1-month she had fully recovered. This case reminds us that Sydenham's chorea can result in major functional impairment. There is some evidence on the beneficial effect of IVIG in the treatment of Sydenham's chorea, as is evident in our case. Therefore, IVIG should be considered as a treatment option in patients with severe chorea.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.